Pharmaceutical composition for preventing or treating nervous system diseases

JP7600131B2Active Publication Date: 2024-12-16GLACEUM INC
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
JP2021550238
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-02-28
Filing Date
2020-02-28
Publication Date
2024-12-16
Estimated Expiration
2040-02-28

AI Technical Summary

Technical Problem

Current treatments for nervous system diseases are inadequate in effectively preventing or treating conditions such as Alzheimer's disease, vascular dementia, Parkinson's disease, and other neurological disorders due to the lack of pharmaceutical compositions that enhance the function of paraoxonase enzymes, which play a crucial role in mitigating oxidative stress and inflammation.

Method used

A pharmaceutical composition containing a pyrano[2,3-f]chromene derivative compound, its pharmaceutically acceptable salts, or solvates, which acts as a PONase activator, improving anti-inflammatory indicators and mitochondrial function, thereby addressing the underlying causes of these diseases.

Benefits of technology

The pyrano[2,3-f]chromene derivative compound demonstrates significant neuroprotective effects by enhancing paraoxonase enzyme activity, reducing oxidative stress, and alleviating inflammation, thus providing effective prevention and treatment for a range of neurological disorders.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007600131000043
    Figure 0007600131000043
  • Figure 0007600131000044
    Figure 0007600131000044
  • Figure 0007600131000045
    Figure 0007600131000045
Patent Text Reader

Abstract

The present invention relates to a pharmaceutical composition for preventing or treating a nervous system disease, comprising a pyrano[2,3-f]chromene derivative compound, a pharmaceutically acceptable salt thereof, or a solvate thereof, and provides a pharmaceutical composition that can improve or protect the function of various enzymes, including paraoxonase.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Tyrosine phosphatase inhibitor

    JP2005089322A

  • Methods of treating diabetes

    JP2010538072A

  • Anticancer agent

    JP2016023140A

  • Pyranocromenylphenol derivatives and pharmaceutical compositions for treating metabolic syndrome or inflammatory diseases

    JP2017501163A

  • Pyranochromenylphenol derivatives and a pharmaceutical composition for treating metabolic syndrome or inflammatory disease

    KR1020150075030A